1. Home
  2. AVDL vs ARMN Comparison

AVDL vs ARMN Comparison

Compare AVDL & ARMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • ARMN
  • Stock Information
  • Founded
  • AVDL 2015
  • ARMN 1992
  • Country
  • AVDL Ireland
  • ARMN Canada
  • Employees
  • AVDL N/A
  • ARMN N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • ARMN
  • Sector
  • AVDL Health Care
  • ARMN
  • Exchange
  • AVDL Nasdaq
  • ARMN Nasdaq
  • Market Cap
  • AVDL 900.2M
  • ARMN 769.7M
  • IPO Year
  • AVDL 1996
  • ARMN N/A
  • Fundamental
  • Price
  • AVDL $9.54
  • ARMN $7.04
  • Analyst Decision
  • AVDL Strong Buy
  • ARMN
  • Analyst Count
  • AVDL 6
  • ARMN 0
  • Target Price
  • AVDL $18.17
  • ARMN N/A
  • AVG Volume (30 Days)
  • AVDL 1.6M
  • ARMN 1.5M
  • Earning Date
  • AVDL 08-07-2025
  • ARMN 08-12-2025
  • Dividend Yield
  • AVDL N/A
  • ARMN N/A
  • EPS Growth
  • AVDL N/A
  • ARMN 28.55
  • EPS
  • AVDL N/A
  • ARMN 0.15
  • Revenue
  • AVDL $194,450,000.00
  • ARMN $560,512,000.00
  • Revenue This Year
  • AVDL $56.88
  • ARMN $49.45
  • Revenue Next Year
  • AVDL $29.81
  • ARMN N/A
  • P/E Ratio
  • AVDL N/A
  • ARMN $44.88
  • Revenue Growth
  • AVDL 252.64
  • ARMN 22.28
  • 52 Week Low
  • AVDL $6.38
  • ARMN $3.29
  • 52 Week High
  • AVDL $17.30
  • ARMN $7.23
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 56.42
  • ARMN 59.49
  • Support Level
  • AVDL $8.74
  • ARMN $6.78
  • Resistance Level
  • AVDL $9.56
  • ARMN $7.23
  • Average True Range (ATR)
  • AVDL 0.39
  • ARMN 0.25
  • MACD
  • AVDL 0.04
  • ARMN -0.01
  • Stochastic Oscillator
  • AVDL 81.92
  • ARMN 78.80

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About ARMN Aris Mining Corporation

Aris Mining Corp is engaged in the acquisition, exploration, development and operation of gold properties in Colombia, Guyana and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, Toroparu Project in Guyana and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.

Share on Social Networks: